Tag: Continuous Glucose Monitor (CGM)
In brief: CGM transformation, MK Battery acquisition, Sava-Ascensia partnership
October 16, 2026HME News Staff
AURORA, Colo. – Continuous glucose monitors (CGMs) could transform disease management for millions of Americans with Type 2 diabetes who don't take insulin, according to new research published in the New England Journal of Medicine.
The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common...
Study: CGM use can improve diabetes management for Type 2 patients
October 15, 2026HME News Staff
AURORA, Colo. – Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with Type 2 diabetes who don't take insulin, according to findings from new research published in the New England Journal of Medicine.
The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below...
Sava receives $36M in funding, partners with Ascensia
October 14, 2026HME News Staff
LONDON – Sava Technologies has received $36 million in Series B funding, alongside an agreement appointing Ascensia, a subsidiary of PHC Holdings Corp., as its commercialization and distribution partner, starting off in Europe. Founded in 2019, Sava has developed a wearable built on its proprietary microsensor technology that measures molecules just beneath the skin, painlessly and continuously. While starting with glucose, the platform is designed to track other biomarkers, too, opening the...
Industry, armed with data, ramps up advocacy for bid relief
October 2, 2026Theresa Flaherty
WASHINGTON – Home medical equipment (HME) stakeholders had several high-level meetings scheduled the week of Sept. 28, including with the Office of Management and Budget (OMB), to discuss the expected negative impact of the next round of Medicare’s competitive bidding program (CBP).
AAHomecare recently released the results of a survey that estimates more than 1,700 DMEPOS companies would be at risk of downsizing or closing down if a new remote-item delivery framework goes into effect...
Dexcom reports on access, attitudes to diabetes technology
September 29, 2026HME News Staff
MILAN – A majority of health care providers (HCPs) recognize continuous glucose monitoring (CGM) as essential to Type 2 diabetes management, according to a new report published by Dexcom ahead of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan Sept. 28-Oct. 2.
Eighty-nine percent of HCPs believe CGM helps them assess treatment adherence between appointments, and more than half of current CGM users report they have followed their treatment plan...
Medically Modern joins Florida Blue network
September 28, 2026HME News Staff
NEW YORK – Medically Modern says it has been invited into the Florida Blue network, allowing the national provider of continuous glucose monitors (CGMs), insulin pumps and related supplies to serve members in every county in the state. Though the network is currently closed to new providers, Medically Modern says the addition was made through an amendment to its existing payer services agreement, as it already serves Florida Blue patients. “Insulin pump technology is in an incredible...
CGM could lower risk of dying for people with diabetes, according to new analysis
September 28, 2026HME News Staff
YARMOUTH, Maine – People with Type 2 diabetes on basal insulin who are starting continuous glucose monitoring (CGM) had a 44% lower risk of dying from any cause after one year compared with those who did not use CGM, according to an analysis of patient data being presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan Sept. 28-Oct. 2. The risk was 35% lower after two years, according to the analysis. Researchers say the analysis provides the first...
Medically Modern builds scale through practice partnerships, payer access
September 25, 2026HME News Staff
NEW YORK – Medically Modern is in growth mode with a new model that uses its insurance expertise and customized technology to help physicians better manage their diabetes patients, says founder and CEO Corey Deutsch.
Medically Modern recently announced a new partnership with an independent, multi-location endocrinology practice in Northern Virginia to manage prior authorization and fulfillment for its continuous glucose monitor (CGM) and insulin pump referrals.
‘We speak fluent...
In brief: CGMs are essential & effective, GLP-1s & CPAP are better together
September 25, 2026HME News Staff
MILAN – A majority of health care providers (HCPs) recognize continuous glucose monitoring (CGM) as essential to Type 2 diabetes management, according to a new report published by Dexcom ahead of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan Sept. 28-Oct. 2.
Eighty-nine percent of HCPs believe CGM helps them assess treatment adherence between appointments, and more than half of current CGM users report they have followed their treatment plan...
Medically Modern partners with endocrinology practice
September 14, 2026HME News Staff
NEW YORK – Medically Modern has a new partnership with an independent, multi-location endocrinology practice in Northern Virginia to manage prior authorization and fulfillment for its continuous glucose monitor (CGM) and insulin pump referrals. The company says the partnership gives the practice’s care team real-time visibility into every referred patient’s prescribed supplies. "We pivoted into this partnership strategy after hearing the same thing from providers over and over:...